Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels

被引:52
作者
Renou, C
Halfon, P
Pol, S
Cacoub, P
Jouve, E
Bronowicki, JP
Arpurt, JP
Rifflet, H
Picon, M
Causse, X
Canva, V
Denis, J
Tran, A
Bourlière, M
Ouzan, D
Pariente, A
Dantin, S
Alric, L
Cartier, V
Reville, M
Caillat-Zucman, S
机构
[1] CH Hyeres, Unite Hepatogastroenterol, Hyeres, France
[2] Lab Alphabio, Marseille, France
[3] Hop Necker Enfants Malad, Serv Hepatogastroenterol, Paris, France
[4] Hop La Pitie Salpetriere, Serv Med Interne, Paris, France
[5] Hop La Timone, CPCET, Marseille, France
[6] CHU Nancy, Serv Hepatogastroenterol, Nancy, France
[7] CH Avignon, Serv Hepatogastroenterol, Avignon, France
[8] CH Ajaccio, Serv Hepatogastroenterol, Ajaccio, France
[9] CH Aix Provence, Serv Hepatogastroenterol, Aix En Provence, France
[10] CHR Orleans, Serv Hepatogastroenterol, Orleans, France
[11] CHU Lille, Serv Hepatogastroenterol, Lille, France
[12] CH Corbeil, Serv Hepatogastroenterol, Corbeil Essonnes, France
[13] CHU Nice, Serv Hepatogastroenterol, Nice, France
[14] Hop St Joseph, Serv Hepatogastroenterol, Marseille, France
[15] CH Pau, Serv Hepatogastroenterol, Pau, France
[16] Prod Roche, Neuilly Sur Seine, France
[17] CHU Toulouse, Serv Med Interne, Toulouse, France
[18] CH Creteil, Serv Hepatogastroenterol, Creteil, France
[19] CHR Metz, Serv Hepatogastroenterol, Metz, France
[20] Hop Necker Enfants Malad, Immunol Lab, Paris, France
关键词
D O I
10.1136/gut.51.4.585
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: A significant proportion of individuals with chronic hepatitis C virus (HCV) infection have persistently normal alanine aminotransferase (ALT) levels. Although data are controversial, such patients usually have weaker histological damage and a lower progression rate of fibrosis. The aims of this study were: (1) to compare demographic, virological, and histological parameters of HCV patients with normal ALT values with those of HCV patients with elevated ALT levels; and (2) to determine whether HLA class II alleles contribute to the persistence of normal ALT levels in HCV patients. Patients and methods: Eighty three patients with chronic HCV infection and persistently normal ALT values (group 1) and 233 patients with chronic HCV infection and elevated ALT levels (group 2) were studied. Histological features were expressed using Knodell and Metavir scores. HLA DRB1* and DQB1* genotyping was performed using hybridisation with sequence specific oligonucleotides after genomic amplification. The chi(2) and Fisher's exact tests were used to compare discrete variables and phenotype frequencies between the two groups, and Wilcoxon's test was used for continuous variables. A multivariate logistic regression model was used to determine which variables predicted normal ALT values. Results: ALT levels were correlated with the severity of liver damage. In group 1, 93% of patients had an F0 or F1 Metavir index of fibrosis compared with 47% of patients in group 2 (p<0.001). A longer duration of infection (p<0.001) and increased DRB1*11 phenotype frequency (pc=0.03) were observed among patients with normal ALT. The two groups did not differ with regard to the mode of contamination or viral genotype. After logistic regression, young age (p=0.0008), female sex (p=0.01), long duration of infection (p=0.0001), and HLA DRB1*11 (p=0.050) were more strongly associated with persistence of normal ALT. Conclusions: Our study confirms that patients with chronic hepatitis C and normal ALT levels have less severe liver disease than those with elevated ALT levels. This particular biochemical outcome may be explained, at least in part, by host immunogenetic factors such as the presence of HLA-DRB1*11.
引用
收藏
页码:585 / 590
页数:6
相关论文
共 44 条
  • [1] Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection
    Alric, L
    Fort, M
    Izopet, J
    Vinel, JP
    Charlet, JP
    Selves, J
    Puel, J
    Pascal, JP
    Duffaut, M
    Abbal, M
    [J]. GASTROENTEROLOGY, 1997, 113 (05) : 1675 - 1681
  • [2] Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection?
    Amoroso, A
    Berrino, M
    Canale, L
    Cornaglia, M
    Guarrera, S
    Mazzola, G
    Savoldi, S
    Scolari, F
    Sällberg, M
    Clementi, M
    Gabrielli, A
    [J]. JOURNAL OF HEPATOLOGY, 1998, 29 (01) : 36 - 44
  • [3] [Anonymous], 1999, J Hepatol, V30, P956
  • [4] Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease
    Asti, M
    Martinetti, M
    Zavaglia, C
    Cuccia, MC
    Gusberti, L
    Tinelli, C
    Cividini, A
    Bruno, S
    Salvaneschi, L
    Ideo, G
    Mondelli, MU
    Silini, EM
    [J]. HEPATOLOGY, 1999, 29 (04) : 1272 - 1279
  • [5] Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin
    Barrett, S
    Ryan, E
    Crowe, J
    [J]. JOURNAL OF HEPATOLOGY, 1999, 30 (06) : 979 - 983
  • [6] BEDOSSA P, 1994, HEPATOLOGY, V20, P15
  • [7] HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders
    Congia, M
    Clemente, MG
    Dessi, C
    Cucca, F
    Mazzoleni, AP
    Frau, F
    Lampis, R
    Cao, A
    Lai, ME
    DeVirgiliis, S
    [J]. HEPATOLOGY, 1996, 24 (06) : 1338 - 1341
  • [8] Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia
    Cramp, ME
    Carucci, P
    Underhill, J
    Naoumov, NV
    Williams, R
    Donaldson, PT
    [J]. JOURNAL OF HEPATOLOGY, 1998, 29 (02) : 207 - 213
  • [9] Management of hepatitis C: A national survey of gastroenterologists and hepatologists
    Everhart, JE
    Stolar, M
    Hoofnagle, JH
    [J]. HEPATOLOGY, 1997, 26 (03) : S78 - S82
  • [10] Viral clearance in hepatitis C (1b) infection: Relationship with human leukocyte antigen class II in a homogeneous population
    Fanning, LJ
    Levis, J
    Kenny-Walsh, E
    Wynne, F
    Whelton, M
    Shanahan, F
    [J]. HEPATOLOGY, 2000, 31 (06) : 1334 - 1337